PKS Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
PKS Advisory Services's PFE Position: Q2 2026 in Review
PKS Advisory Services opened a new position in Pfizer (PFE) in Q2 2026: 8,336 shares worth $201K. The stake represents 0.03% of the portfolio and ranks #362 among its holdings. This is a return to the name: PKS Advisory Services previously reported a position in PFE as recently as Q4 2025.
PKS Advisory Services first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $327K in Q1 2025. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- PKS Advisory Services held 8,336 shares of Pfizer worth $201K as of Q2 2026.
- Pfizer was a new PKS Advisory Services position in Q2 2026.
- Pfizer made up 0.03% of PKS Advisory Services's portfolio in Q2 2026, its #362 holding.
- PKS Advisory Services first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
- PKS Advisory Services's Pfizer position peaked at $327K in Q1 2025.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on PKS Advisory Services's 13F filing for Q2 2026, filed 4 Aug 2026.